Evidence map›Paper›PMID 35296718›Full record

ArticleScientific reports2022

Expanding the clinical spectrum of COL2A1 related disorders by a mass like phenotype.

Till Joscha Demal, Tasja Scholz, Helke Schüler, Jakob Olfe, Anja Fröhlich, Fabian Speth, Yskert von Kodolitsch, Thomas S Mir, Hermann Reichenspurner, Christian Kubisch and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Ocular and Systemic Findings in COL2A1 and COL11A1 Stickler Syndrome.American journal of medical genetics. Part A · 2026
    Article
  2. Article
  3. Pathogenicity effects of aTranslational pediatrics · 2025
    Article
  4. Article
  5. Genetic factors underlying Mandibular prognathism: insights from recent human and animal studies.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Till Joscha Demal *Department of Cardiovascular Surgery, University Heart & Vascular Center Hamburg, Hamburg, Germany.
Tasja Scholz *Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Helke SchülerDepartment of Cardiology, University Heart & Vascular Center Hamburg, Hamburg, Germany.
Jakob OlfePediatric Cardiology Clinic, University Heart & Vascular Center Hamburg, Hamburg, Germany.
Anja FröhlichDepartment of Paediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fabian SpethDepartment of Paediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Yskert von KodolitschDepartment of Cardiology, University Heart & Vascular Center Hamburg, Hamburg, Germany.
Thomas S MirPediatric Cardiology Clinic, University Heart & Vascular Center Hamburg, Hamburg, Germany.
Hermann ReichenspurnerDepartment of Cardiovascular Surgery, University Heart & Vascular Center Hamburg, Hamburg, Germany.
Christian KubischInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Maja Hempel *Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Georg Rosenberger *Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. rosenberger@uke.de.ORCID 0000-0003-3625-3109
Universität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MASS phenotype is a connective tissue disorder clinically overlapping with Marfan syndrome and caused by pathogenic variants in FBN1. We report four patients from three families presenting with a MASS-like phenotype consisting of tall stature, arachnodactyly, spinal deformations, dural ectasia, pectus and/or feet deformations, osteoarthritis, and/or high arched palate. Gene panel sequencing was negative for FBN1 variants. However, it revealed likely pathogenic missense variants in three individuals [c.3936G > T p.(Lys1312Asn), c.193G > A p.(Asp65Asn)] and a missense variant of unknown significance in the fourth patient [c.4013G > A p.(Ser1338Asn)] in propeptide coding regions of COL2A1. Pathogenic COL2A1 variants are associated with type II collagenopathies comprising a remarkable clinical variablility. Main features include skeletal dysplasia, ocular anomalies, and auditory defects. A MASS-like phenotype has not been associated with COL2A1 variants before. Thus, the identification of likely pathogenic COL2A1 variants in our patients expands the phenotypic spectrum of type II collagenopathies and suggests that a MASS-like phenotype can be assigned to various hereditary disorders of connective tissue. We compare the phenotypes of our patients with related disorders of connective tissue and discuss possible pathomechanisms and genotype-phenotype correlations for the identified COL2A1 variants. Our data recommend COL2A1 sequencing in FBN1-negative patients suggestive for MASS/Marfan-like phenotype (without aortopathy).

Indexed as

Marfan SyndromeCollagen Type IIGenotypeHumansMitral Valve ProlapseMutationMyopiaPhenotypeSkin DiseasesCOL2A1 protein, humanCollagen Type II

Identifiers

PMID35296718
PMCPMC8927422
OpenAlexW4220913437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.